Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

143
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
143
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
The Ras Gene02:38

The Ras Gene

6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost Utility Analysis of Covered vs. Bare Metal Stenting of the Mesenteric Arteries in Patients with Chronic Mesenteric Ischaemia: Results of a Multicentre Randomised Controlled Trial (CoBaGI).

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Bridging the Gap between Literature and Practice: Nationwide Outcomes of Endoscopic Ultrasound-guided Hepatico-gastrostomy.

Endoscopy international open·2026
Same author

Endoscopic Ultrasonography-Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health-Economic Evaluation Alongside a Randomized Trial.

United European gastroenterology journal·2026
Same author

Urgent versus early ERCP in mild-to-moderate acute cholangitis: a randomised controlled trial.

Gut·2026
Same author

Antibiotic-associated <i>Enterococcus</i> expansion in the gastrointestinal tract precedes infected necrosis in acute necrotizing pancreatitis.

Gut microbes·2026
Same author

Optimal Timing of Endoscopic Necrosectomy in Patients With Symptomatic Necrotizing Pancreatitis Following Catheter Drainage: Still Wondering.

Gastroenterology·2026

Related Experiment Video

Updated: Aug 31, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

899

Hereditary pancreatic cancer.

Derk C F Klatte1, Michael B Wallace2, Matthias Löhr3

  • 1Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands; Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, United States.

Best Practice & Research. Clinical Gastroenterology
|August 21, 2022
PubMed
Summary

Early detection of pancreatic cancer is crucial. Hereditary pancreatic cancer surveillance offers benefits but carries risks like overtreatment, necessitating careful management strategies.

Keywords:
Familial pancreatic cancerHereditary pancreatic cancerHigh-risk individualsPancreatic ductal adenocarcinomaSurveillance

More Related Videos

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

3.0K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

496

Related Experiment Videos

Last Updated: Aug 31, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

899
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

3.0K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

496

Area of Science:

  • Oncology
  • Genetics
  • Public Health

Background:

  • Pancreatic cancer is a highly lethal malignancy with poor survival rates.
  • Hereditary cancer syndromes significantly increase pancreatic cancer risk.
  • Early detection through surveillance is vital for improving patient outcomes.

Purpose of the Study:

  • To review definitions, epidemiology, and risk factors of hereditary pancreatic cancer.
  • To outline recommendations for genetic testing and surveillance programs.
  • To discuss surveillance strategies, target lesions, benefits, and harms.

Main Methods:

  • Literature review of hereditary pancreatic cancer.
  • Analysis of current genetic testing guidelines.
  • Evaluation of surveillance program efficacy and risks.

Main Results:

  • Hereditary factors contribute to a subset of pancreatic cancer cases.
  • Surveillance programs can improve early detection rates.
  • Overtreatment and associated risks are significant concerns in surveillance.

Conclusions:

  • Genetic testing is key for identifying individuals at high risk.
  • Tailored surveillance strategies are needed to balance benefits and harms.
  • Future research should focus on optimizing care for high-risk populations.